1. Remedial Dosing Recommendations for Sirolimus Delayed or Missed Dosages Caused by Poor Medication Compliance in Pediatric Tuberous Sclerosis Complex Patients
   Yang Yang et al, 2024, Current Pharmaceutical Design CrossRef
2. Initial Dosage Recommendation for Sirolimus in Children With Tuberous Sclerosis Complex
   Dong-Dong Wang et al, 2020, Frontiers in Pharmacology CrossRef
3. GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes
   Gene I. Uenishi et al, 2024, JCI Insight CrossRef